Regorafenib monohydrate | B1621

Regorafenib monohydrate is a multi-targeted inhibitor tyrosine kinase

Regorafenib monohydrate is a multi-targeted inhibitor tyrosine kinase

B1621 | Regorafenib monohydrate DataSheet

Alternate Name/Synonyms: Regorafenib monohydrate, BAY 73-4506 monohydrate; BAY 73 4506 monohydrate; BAY 734506 monohydrate; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide;hydrate; Regorafenib hydrate; Tyrosine kinase inhibitor

Appearance: Solid

Formulation: N/A

CAS Number: 1019206-88-2

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₂₁H₁₇ClF₄N₄O₄

Molecular Weight: 500.83

Cell-Permeable?: Yes

Purity: 0.9951

Solubilities: DMSO

Handling: Protect from air and light

Country of Origin: USA

Tag Line: A multi-targeted inhibitor tyrosine kinase

MDL Number: MFCD17170366

PubChem CID: 24768591

SMILES: CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F.O

InChi: 1S/C21H15ClF4N4O3.H2O/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26;/h2-10H,1H3,(H,27,31)(H2,29,30,32);1H2

InChi Key: ZOPOQLDXFHBOIH-UHFFFAOYSA-N